Report #2849269

Received Jul 10, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 18 yrs
State: NY
Recovered: Unknown
Vaccinated: Jun 26, 2025
Onset: Jun 26, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
MNQ	MENINGOCOCCAL CONJUGATE (MENVEO)	NOVARTIS VACCINES AND DIAGNOSTICS	UNK	AMXB030A	—

Symptoms (1)

Product preparation issue

Symptom narrative

administration of Menveo diluent only to a patient; administration of Menveo diluent only to a patient; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 18-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMXB030A, expiry date 31-DEC-2025) for prophylaxis. On 26-JUN-2025, the patient received Menveo. On 26-JUN-2025, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: administration of Menveo diluent only to a patient) and inappropriate dose of vaccine administered (Verbatim: administration of Menveo diluent only to a patient). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK receipt date: 27-JUN-2025 A registered pharmacist reported that the administration of Menveo diluent only to a patient on 26th June 2025 which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.